Alpine Immune Sciences price target raised to $11 from $8 at H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis raised the firm’s price target on Alpine Immune Sciences to $11 from $8 and keeps a Buy rating on the shares post the Q4 results.